Teva Comments On Sandoz Implications Amid Strategic Review

Israeli Firm Has Ruled Itself Out Of Merging With Novartis Unit

 
• By Dean Rudge
  
Teva has offered its opinion on the potential Sandoz deal • Source: Alamy

More from Business

More from Generics Bulletin